Gharaee-Kermani et al., 1998 - Google Patents
The role of IL-5 in bleomycin-induced pulmonary fibrosisGharaee-Kermani et al., 1998
View PDF- Document ID
- 13396079146984518337
- Author
- Gharaee-Kermani M
- McGarry B
- Lukacs N
- Huffnagle G
- Egan R
- Phan S
- Publication year
- Publication venue
- Journal of leukocyte biology
External Links
Snippet
Eosinophils are known to express cytokines capable of promoting fibrosis. Interleukin-5 (IL- 5) is important in regulating eosinophilopoiesis, eosinophil recruitment and activation. Lung IL-5 expression is elevated in pulmonary fibrosis, wherein the eosinophil is a primary source …
- 108010002616 Interleukin-5 0 title abstract description 62
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gharaee-Kermani et al. | The role of IL-5 in bleomycin-induced pulmonary fibrosis | |
Zhang et al. | TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. | |
Tager et al. | Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10 | |
Huaux et al. | Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis | |
Smith et al. | TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury | |
Stahl et al. | Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis | |
Eming et al. | Accelerated wound closure in mice deficient for interleukin-10 | |
Gharaee-Kermani et al. | CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis | |
Cooper et al. | IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. | |
Rolfe et al. | Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking | |
Schnyder-Candrian et al. | Interleukin-17 is a negative regulator of established allergic asthma | |
Nagai et al. | Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis | |
Tetta et al. | Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. | |
Williams et al. | Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo | |
Martinet et al. | Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes | |
Wang et al. | By homing to the kidney, activated macrophages potently exacerbate renal injury | |
Rolfe et al. | Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1 | |
Pechkovsky et al. | CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II | |
Suga et al. | CXCR3 deficiency prolongs Th1-type contact hypersensitivity | |
US20080175815A1 (en) | Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment or related conditions | |
JP2011219501A (en) | Cytokine use; composition; method | |
Christensen et al. | Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis | |
Hogmalm et al. | β6 integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia | |
Karkar et al. | Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6 | |
Hirayama et al. | Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anaemia and myelodysplastic syndrome |